
Samir Mitra
Founder & CEO of Reya.ai (formerly Reya Health), a Silicon Valley longevity-intelligence and AI healthcare platform built for preventive care clinics.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Aug 30, 2026
Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health
18:54
19:10
19:19
19:25
19:32
D
18:46DaphnaHOST
Tell us a little bit about Rea.ai and what you're trying to achieve with your company, what gaps you're trying to fill.

Samir MitraGUEST
Rea.ai is basically an AI software company that is trying to make longevity more meaningful in terms of what people need to do daily, how they should eat, how they should sleep.

Samir MitraGUEST
And today you get a lot of data about yourself, but you're not able to really interpret that.

Samir MitraGUEST
And so we're really trying to reduce the noise ratio and make it more meaningful to people.

Samir MitraGUEST
And we think AI is going to be critical in that, especially in the longevity space, because longevity inherently has a lot of data.

Samir MitraGUEST
So if you kind of look at your body, Your body can emit tons of data and we're getting a lot of measurable devices like the whoop and the auras, but there's going to be so much more coming down the road that your body is going to be a massive source of data and it's real time.
D
24:36DaphnaHOST
Now, how involved is the clinician still once they get the information from Rhea, once they get the analysis? What does the clinician still have to do or should do before implementing a protocol or speaking to the patient?